Anzeige
Mehr »
Login
Sonntag, 29.09.2024 Börsentäglich über 12.000 News von 691 internationalen Medien
Von 0,059 € auf 0,26 €: Die Gold-Aktie, die alle Erwartungen übertrifft
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
384 Leser
Artikel bewerten:
(1)

In-Vitro Fertilization Market Size Worth USD 31.97 Billion by 2027 | CAGR of 9.1%: Emergen Research

- Increasing infertility cases and the advancement of new technologies, such as lensless sperm imaging, are expected to propel the growth of the in-vitro fertilization industry in the forecast period.

- In-Vitro Fertilization Market Size - USD 15.87 Billion in 2019, In-Vitro Fertilization Market Growth - CAGR of 9.1%, In-Vitro Fertilization Industry Trends- High demand from developing nations

VANCOUVER, BC, Sept. 23, 2020 /PRNewswire/ --The Global In-Vitro Fertilization Market is forecast to reach USD 31.97 Billion by 2027, according to a new report by Emergen Research. The growth of the sector is facilitated by rising occurrences of infertility attributable to behavioral improvements, policy measures to have fair insurance schemes, and ongoing efforts by suppliers in the industry. The development of fertility therapies to treat male infertility, such as ICSI, is expected to have a positive impact on market growth. In turn, the provision of genomic testing to deter genetic disorder transfer through in-vitro fertilization (IVF) usage is also projected to push the IVF industry. The increase of IVF treatment has led to more insurance players covering the procedures. It led directly to competitive rates and moderated the costs of IVF treatment, as the process was a successfully mastered technology that has driven the market with more optimization and automation of therapy. The main factor leading to reduced Total Fertility Rate (TFR) is a behavioral change in culture. These factors include a growing number of women in the workforce, higher first-born age, urbanization, lower marriage rates, and changing attitude towards marriage.

Emergen_Research_Logo

Growing consumer understanding of infertility and the development of various therapies are anticipated to fuel business growth. Any other reasons, such as the availability of innovative drugs, decreased male infertility, reduced alcohol & tobacco use, and increased policy efforts to improve IVF care, are projected to further fuel consumer demand.

According to the American Society for Pregnant Medicine (ASRM), approximately 6.7 million people in the U.S. are impacted by the inability to conceive, which accounts for around 11.0% of the reproductive population. Additionally, 25% of couples have more than one factor that can cause infertility. Researchers have also developed methods that are used beforehand to improve the effective rate of in-vitro fertilization. Specific methods such as aided hatching, vitrification, processing of egg/sperm, percutaneous epidydimal sperm accumulation and testicular sperm retrieval (PESA and TESE), mini IVF, tri-parent IVF, and genetic testing are already being utilized. Due to the broad target demographic, low treatment cost than developing countries, and availability of advanced technologies, Asia Pacific held the largest market share with regard to the number of IVF cycles conducted in 2019.

Request free sample of this research report at: https://www.emergenresearch.com/request-sample/19

Further key findings from the report suggest

  • Based on instrument, disposable devices generated a revenue of USD 5.27 billion in 2019 and is estimated to rise with a CAGR of 9.5% in the forecast period. Due to the need for high sterile conditions and strict regulatory requirements, market players are incorporating disposable devices such as needles, slides, and chambers.
  • The fresh non-donor procedure segment is expected to grow with a CAGR of 9.3% in the forecast period owing to the steady success rate in the first attempt.
  • The fertility clinic application is the major contributor to the In-Vitro Fertilization Market. The fertility clinics application of the European region is leading the market segment and held around 64.0% of the market in the year 2019. Owing to the growing demands for ART treatments, there is a significant increase in the number of fertility centers and ART centers, which provide counseling for couples with conceiving problems.
  • Europe dominated the market for In-Vitro Fertilization in 2019 as it became the first to develop the in-vitro fertilization method to delete the controversial title from the cryopreservation of sperm and the first to officially authorize IVF or the mitochondrial fusion strategy of the three parents. The European region held approximately 35.1% of the market, followed by North America, contributing to around 31.0% of the market share in the year 2019.
  • Key participants include Thermo Fisher Scientific Inc., Irvine Scientific, OvaScience, Cooper Surgical Inc., EMD Serono Inc., Cook Medical Inc., Cardone & Associates Reproductive Medicine & Infertility LLC, Morpheus Life Sciences Pvt. Ltd., Vitrolife AB, and Genea Biomedx, among others.

To get leading market solutions, visit the link below:
https://www.emergenresearch.com/industry-report/in-vitro-fertilization-market

For the purpose of this report, Emergen Research has segmented the global In-Vitro Fertilization market based on the procedure type, instrument, application, and region:

Procedure Type Outlook (Revenue, USD Billion; 2017-2027)

  • Fresh Donor
  • Frozen Donor
  • Fresh Non-donor
  • Frozen Non-donor

Instrument Outlook (Revenue, USD Billion; 2017-2027)

  • Disposable Devices
  • Culture Media
  • Capital Equipment

Application Outlook (Revenue, USD Billion; 2017-2027)

  • Fertility Clinics
  • Hospitals
  • Others

Regional Outlook (Revenue, USD Billion; 2017-2027)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Benelux
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA

Find more similar research insights by Emergen Research:

Injectable Drug Delivery Market By Product Type (Formulations, Devices), By Therapeutic Application (Hormonal disorders, Autoimmune disorders, Oncology), By End-User (Homecare settings, Hospitals & Clinics), Forecasts to 2027

Surgical Robotics Market By Types (Neurosurgery, Spinal surgery, ENT Surgery, Orthopedic Surgery, Robotic Radiosurgery System), By Applications (Pediatrics, Adults, Geriatrics), By End Use (Hospitals, Ambulatory Care Centers, Others), and Regions Forecasts to 2027

Animal Genetics Market By Live Animals (Porcine, Bovine, Poultry, Canine and Others), By Genetic Materials (Embryo, Semen) and By Services (Genetic Trait Testing, Genetic Disease Testing, DNA Type Testing) Forecasts to 2027

Women's Health Market By Product Type, By Application (Contraceptives, Postmenopausal Osteoporosis, Hormonal Infertility, Menopause, Endometriosis, Polycystic Ovary Syndrome (PCOS)), By End-Users (Hospitals & Clinics, Obstetrics & Gynecology Centers, Ambulatory Surgical Centers, Research Institutes), Forecasts to 2027

Ventilator Market By Interface (Invasive, Non-Invasive), By Type (Adults/Pediatric, Neonatal/Infants, By Mode (Pressure, Volume, Dual/Combined Mode), By End-Users (Hospitals, Home Care Settings, Ambulatory Care Centers, Emergency Medical Services), Forecasts to 2027

Sports Medicine Market By Product (Body Reconstruction Products, Body Support and Recovery Products), By Application (Knee Injuries, Shoulder Injuries, Foot and Ankle Injuries), By Body Monitoring and Evaluation Devices, By End-Use, and By Region, and By Region, Forecasts to 2027

About Emergen Research

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

With market-leading insights and an in-depth understanding of leading and niche technologies, our solutions address the most pertinent questions for your business needs. A major technological shift has been witnessed towards creating a 'Circular Economy,' fuelled by factors, such as the increased adoption of bio-based materials, along with other methods for achieving carbon neutrality. We are conversant in technologies, viz., Artificial Intelligence (AI), Augmented Reality (AR), Virtual Reality (VR), Robotic Process Automation (RPA), Smart Manufacturing, Internet of Things (IoT), Big Data Analytics, Machine learning, Nanotechnology, Edge Computing, Blockchain Technology, Cloud Computing, Vehicle Electrification, Advanced Maintenance Analytics, and Predictive Maintenance, among other prevalent and emergent technologies.

Contact Us:

Eric Lee
Corporate Sales Specialist
Emergen Research | Web: https://www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com

Read full Press Release at: https://www.emergenresearch.com/press-release/global-in-vitro-fertilization-market

Logo: https://mma.prnewswire.com/media/1252126/Emergen_Research_Logo.jpg

© 2020 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.